Skip to main content
Select Page
Schedule Today!

What Is The UV Index?

by | May 14, 2016 | Skin Cancer, Mohs Micrographic Surgery, How to Protect Yourself From the Sun, Actinic Keratosis, How To Stay Healthy, Sunscreen, Skin In The News, Guide to The Summer, Outdoor Fun, Basal Cell Carcinoma, Squamous Cell Carcinoma, Melanoma, malignancy

The term “UV Index” is often referenced on the morning news and during weather reports, but are you fully aware of what the UV Index is? UV Index, or the Ultraviolet Index, is a measure of the ultraviolet radiation emitted by the sun. These UV rays are...

What is the Role of Filaggrin in Atopic Dermatitis? Your Genetics Are An Important Factor

by | Feb 16, 2016 | Eczema, Pediatric Dermatology, Dermatitis, Allergies, Skin In The News, Rashes, Inflammation, Adverse Skin Reactions, Itching, Skin, Hands, Body, Face

If you suffer from Atopic Dermatitis, you may wonder what’s causing your red and itchy skin. As it turns out, your genetics play an important part in your skin disease. What is Filaggrin, and What Does it Do? Filaggrin is a class of structural proteins found in...

Celebrities with Psoriasis: 5 Celebrities Dealing With The Skin Condition

by | Nov 6, 2015 | Skin Care, Psoriasis, Skin In The News, Skin Lesions, Rashes, Celebrities, Inflammation, Stress, Itching, Skin, Emotional Impact, Swelling, Body

Psoriasis affects millions of people. In fact, some research suggests that it affects nearly 7.5 millions Americans. So if you suffer from this skin condition, rest assured that you’re not alone – celebrities with Psoriasis must deal with the daily...

Eczema and Vitiligo Patients Wonder: Is Xeljanz a new treatment option for us?

by | Sep 13, 2015 | Skin Care, Practice News, Eczema, Dermatitis, Hair Loss, Medications, Skin In The News, Alopecia, Inflammation, Treatments

Xeljanz (tofacitinib citrate), made by Pfizer, Inc., belongs to a class of drugs known as kinase inhibitors. The drug works by blocking the substances in your body that cause inflammation. Xeljanz has been show to provide relief to moderate to severe sufferers of the...

Odomzo (Sonidegib) Approved For Treatment of Basal Cell Carcinoma

by | Jul 28, 2015 | Skin Cancer, Mohs Micrographic Surgery, Medications, Skin Tumor, Skin In The News, Basal Cell Carcinoma, Squamous Cell Carcinoma, Melanoma, malignancy

With skin cancer rates continuing to soar, new innovative treatments are needed to treat the different presentations of this disease. Basal Cell Carcinoma is the most common form of skin cancer that affects humans. With up to 20% of Americans now developing melanoma...
Accessibility by WAH
Sanova Dermatology
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.